Cholangiocarcinoma classification: current approach, relevance and challenges
J Clin Pathol
.
2024 Dec 14:jcp-2024-209708.
doi: 10.1136/jcp-2024-209708.
Online ahead of print.
Authors
Benjamin Goeppert
1
2
,
Yoh Zen
3
,
Juan Valle
4
,
David Klimstra
5
,
Vikram Deshpande
6
Affiliations
1
Institute of Pathology, Regionale Kliniken Holding RKH GmbH, Ludwigsburg, Germany.
2
Institute of Pathology, Heidelberg University, Heidelberg, Germany.
3
Liver Institute, King's College Hospital, London, UK.
4
Research Department, Cholangiocarcinoma Foundation, Herriman, Utah, USA.
5
Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
6
Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
[email protected]
.
PMID:
39674584
DOI:
10.1136/jcp-2024-209708
No abstract available
Keywords:
Biomarkers, Tumor; CHOLANGIOCARCINOMA; NEOPLASMS.
Publication types
Editorial